Bill Olson

Bill Olson, PhD, joined Regeneron in 2013 as Vice President and serves as Senior Vice President of Therapeutic Proteins, where he is responsible for antibody generation, a key component of drug discovery, through innovative technologies. Before joining Regeneron, Dr. Olson was at Progenics Pharmaceuticals for 19 years. Previously, he was a scientist at MicroGeneSys and Johnson & Johnson’s RW Johnson Pharmaceutical Research Institute. Dr. Olson received his Bachelor of Science in Chemical Engineering at the University of North Dakota, and his PhD in Biochemical Engineering from Massachusetts Institute of Technology.